B

Braster SA
WSE:BRA

Watchlist Manager
Braster SA
WSE:BRA
Watchlist
Price: 0.58 PLN Market Closed
Market Cap: zł17m

Operating Margin

-1 108.8%
Current
Declining
by 635.2%
vs 3-y average of -473.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 108.8%
=
Operating Income
zł-3.1m
/
Revenue
zł284k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 108.8%
=
Operating Income
zł-3.1m
/
Revenue
zł284k

Peer Comparison

Country Company Market Cap Operating
Margin
PL
Braster SA
WSE:BRA
17m PLN
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 95% of companies in Poland
Percentile
5th
Based on 835 companies
5th percentile
-1 108.8%
Low
-10 083 900% — -1.5%
Typical Range
-1.5% — 11.7%
High
11.7% — 195 905.3%
Distribution Statistics
Poland
Min -10 083 900%
30th Percentile -1.5%
Median 5.4%
70th Percentile 11.7%
Max 195 905.3%

Braster SA
Glance View

Market Cap
17m PLN
Industry
Health Care

Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

BRA Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 108.8%
=
Operating Income
zł-3.1m
/
Revenue
zł284k
What is Braster SA's current Operating Margin?

The current Operating Margin for Braster SA is -1 108.8%, which is below its 3-year median of -473.6%.

How has Operating Margin changed over time?

Over the last 3 years, Braster SA’s Operating Margin has increased from -1 900.4% to -1 108.8%. During this period, it reached a low of -1 900.4% on Mar 3, 2021 and a high of -104.5% on Mar 31, 2023.

Back to Top